Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Berg Life Science Consulting AB
AB
Active
Org 5590085782
Ängsviksvägen 8
Business and other management consultancy activities · NACE 7020
Est. 2015
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 120K
EBITDA margin
77.4%
+1416% vs 2024
Equity ratio
45.4%
Financial strength
Net profit 2025
SEK 83K
+1276% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 120K
—
EBITDA
SEK 93K
+1416%
Net profit
SEK 83K
+1276%
Total assets
SEK 238K
+96%
Equity
SEK 108K
+331%
Employees
0
—
Company information
Legal name
Berg Life Science Consulting AB
Org number
5590085782
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
24 mars 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Arbetar med konsultverksamhet inom Life Science
Contact
Address
Ängsviksvägen 8
Email
stefan.berg@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Ekerö
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
—
120
Staff expenses
—
—
—
—
—
EBITDA
−15
−17
−10
−7
93
Depreciation & amort.
−0
—
—
—
—
EBIT
−15
−17
−10
−7
93
Net financials
—
0
0
0
0
Profit before tax
−15
−17
−10
−7
87
Tax
−0
—
—
—
−4
Net profit
−15
−17
−10
−7
83
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
156
138
128
121
238
Equity
32
29
29
25
108
Long-term debt
0
—
—
—
—
Short-term debt
124
109
99
96
124
Total debt
124
109
99
96
124
Financial ratios
5-year trend
EBITDA margin
77.4%
This company
15.8%
Market median
+390% vs market
2021
2025
Equity ratio
45.4%
This company
38.2%
Market median
+19% vs market
2021
2025
Return on equity
76.8%
This company
18.4%
Market median
+317% vs market
2021
2025
Net profit margin
69.1%
This company
8.1%
Market median
+753% vs market
2021
2025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
2021
2025
Debt / equity
1.20×
This company
0.62×
Market median
-94% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JS
Jan Stefan Christer Berg
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
AC
Ann Christine Wåhlstedt Berg
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Berg Life Science Consulting AB also hold positions in
0
other companies.
Person
Role here
Other companies
Jan Stefan Christer Berg
Chief Executive Officer
0 companies
Ann Christine Wåhlstedt Berg
Deputy Board Member
0 companies